Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.

Richardson AB, Chatterjee P, Rosati R, Rajewski A, Diaz RL, Appleyard LR, Pereira S, Bernard B, Javle MM, King GG, Diehl A, Harris WP, Roychowdhury S, Kemp CJ, Grandori C

Open source

DOI: 10.1158/2767-9764.crc-25-0792
Published: 2026 Aug 1
Container: Cancer research communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-25-0792,
  title = {Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.},
  author = {Richardson AB and Chatterjee P and Rosati R and Rajewski A and Diaz RL and Appleyard LR and Pereira S and Bernard B and Javle MM and King GG and Diehl A and Harris WP and Roychowdhury S and Kemp CJ and Grandori C},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-25-0792},
  url = {https://doi.org/10.1158/2767-9764.crc-25-0792}
}

RIS

TY  - JOUR
TI  - Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.
AU  - Richardson AB
AU  - Chatterjee P
AU  - Rosati R
AU  - Rajewski A
AU  - Diaz RL
AU  - Appleyard LR
AU  - Pereira S
AU  - Bernard B
AU  - Javle MM
AU  - King GG
AU  - Diehl A
AU  - Harris WP
AU  - Roychowdhury S
AU  - Kemp CJ
AU  - Grandori C
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-25-0792
UR  - https://doi.org/10.1158/2767-9764.crc-25-0792
ER  -

APA

AB, R., P, C., R, R., A, R., RL, D., LR, A., S, P., B, B., MM, J., GG, K., A, D., WP, H., S, R., CJ, K., & C, G. (2026). Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-25-0792

Source records

pubmed · retrieved 2026-09-26T19:18:12.250Z